Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Xenetic Biosciences Inc | XBIO | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
3.75 | 3.75 | 4.1299 | 4.0899 | 3.7759 |
Recent News
Date | Time | Source | Heading |
---|---|---|---|
2/12/2024 | 09:15 | EDGAR2 | Form 8-K - Current report |
12/18/2023 | 17:18 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/18/2023 | 17:16 | EDGAR2 | Form 3 - Initial statement of beneficial ownership of.. |
12/08/2023 | 17:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/08/2023 | 17:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/08/2023 | 17:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/08/2023 | 17:30 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
12/08/2023 | 17:00 | EDGAR2 | Form 8-K - Current report |
11/13/2023 | 17:00 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
11/13/2023 | 08:30 | EDGAR2 | Form 8-K - Current report |
11/09/2023 | 17:00 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
9/18/2023 | 12:21 | EDGAR2 | Form SC 13D/A - General statement of acquisition of.. |
8/11/2023 | 08:05 | EDGAR2 | Form 8-K - Current report |
8/10/2023 | 16:30 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |